tracking the news, one byte at a time
Freak Pulse
Category: Alzheimer’s Disease and Frontal Temporal Dementia
-
Roundup: FTD Treatment & Genetics, Black Box Warnings for Antipsychotics, and more.
Frontotemporal Signals this week: A clinical review outlines the severe limitations and risks of psychotropic medication for managing neuropsychiatric; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it…
-
Roundup: Blood Signals, Blood test has potential detect earliest signals Alzheimer’s, and more.
Blood Signals this week: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete…
-
Roundup: Cervomed Signals, CervoMed Announces Data 2026 AAN Annual Meeting, and more.
Cervomed Signals this week: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a…
-
Roundup: Policy, FDA approves much-debated Alzheimer’s drug panned experts, and more.
Policy, Courts, And Regulation this week: The FDA has granted accelerated approval to Biogen and Eisai’s aducanumab (Aduhelm) for Alzheimer’s disease, marking; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because…
-
Roundup: Dementia Research Challenges &, Blog Why Normal Cognition, and more.
Dementia Research Challenges & Community Insights this week: Preclinical Alzheimer’s trials targeting amyloid-positive but cognitively unimpaired individuals have repeatedly; and ENRICH Scotland’s Clinical Studies Officer details…
-
Roundup: Blood Biomarkers for Dementia, p-tau217 goes commercial, and more.
Blood Tests & Biomarkers for Dementia Detection this week: A private healthcare provider, Echelon Health, is marketing a comprehensive dementia assessment that integrates the; and Rite Aid is offering p-tau217 blood testing as a…
-
Roundup: Evaluating Alzheimer’s Drugs &, Alzheimers Drugs Provide No, and more.
Evaluating Alzheimer’s Drugs & Treatments this week: A 2026 Cochrane Review analysis of 17 clinical trials involving over 20,000 participants concludes that anti-amyloid; and This matters for Alzheimer’s Disease and Frontal Temporal…